Modulation of adenosine A1 and A2A receptors in C6 glioma cells during hypoxia: Involvement of endogenous adenosine

Journal of Neurochemistry

Volumn 105, Issue 6, 2008, Pages 2315-2329

  Castillo, Carlos A ^a   León, David ^a   Ruiz, María Angeles ^a   Albasanz, José Luis ^a   Martín, Mairena ^a,b  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b Analytical Chemistry and Food Science Dept   (Spain)

Author keywords

Adenosine receptors; C6 glioma cells; Down regulation; Hypoxia

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 3ALPHA; OXYGEN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL VIABILITY; GENE EXPRESSION; GLIOMA CELL; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; CELL HYPOXIA; COMPARATIVE STUDY; DOWN REGULATION; DRUG ANTAGONISM; GLIOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION;

ADENOSINE; ANIMALS; CELL HYPOXIA; CELL LINE, TUMOR; DOWN-REGULATION; GLIOMA; RATS; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; UP-REGULATION;

EID: 44649139199     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05314.x     Document Type: Article

References (78)

1. Abbracchio M. P., Fogliatto G., Paoletti A. M., Rovati G. E. Cattabeni F. (1992) Prolonged in vitro exposure of rat brain slices to adenosine analogues: selective desensitization of adenosine A1 but not A2 receptors. Eur. J. Pharmacol. 227, 317 324.
2. Aebersold D. M., Burrl P., Beer K. T., Laissue J., Djonov V., Greiner R. H. Semenza G. L. (2001) Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61, 2911 2916.
3. Albasanz J. L., Ros M. Martin M. (1997) Characterization of metabotropic glutamate receptors in rat C6 glioma cells. Eur. J. Pharmacol. 326, 85 91.
4. Albasanz J. L., Fernandez M. Martin M. (2002) Internalization of metabotropic glutamate receptor in C6 cells through clathrin-coated vesicles. Brain Res. Mol. Brain Res. 99, 54 66.
5. Arslan G., Kull B. Fredholm B. B. (2002) Anoxia redistributes adenosine A(2A) receptors in PC12 cells and increases receptor-mediated formation of cAMP. Naunyn Schmiedebergs Arch. Pharmacol. 365, 150 157.
6. Baker J. G. Hill S. J. (2007a) A comparison of the antagonist affinities for the Gi- and Gs-coupled states of the human adenosine A1-receptor. J. Pharmacol. Exp. Ther. 320, 218 228.
7. Baker J. G. Hill S. J. (2007b) Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates. Trends Pharmacol. Sci. 28, 374 381.
8. Becher A. McIlhinney R. A. (2005) Consequences of lipid raft association on G-protein-coupled receptor function, in Lipids, Rafts and Traffic: Chapter 15, Biochem. Soc. Symp. pp. 151 164.
9. Boison D. (2006) Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends Pharmacol. Sci. 27, 652 658.
10. Castillo C. A., Albasanz J. L., Fernandez M. Martin M. (2007) Endogenous expression of adenosine A(1), A (2)and A (3) receptors in rat C6 glioma cells. Neurochem. Res. 32, 1056 1070.
11. Chiang M. C., Lee Y. C., Huang C. L. Chern Y. (2005) cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues. J. Biol. Chem. 280, 14331 14340.
12. Coelho J. E., Rebola N., Fragata I., Ribeiro J. A., de Mendonça A. Cunha R. A. (2006) Hypoxia-induced desensitization and internalization of adenosine A1 receptors in the rat hippocampus. Neuroscience 138, 1195 1203.
13. Cordeaux Y., Ijzerman A.P. Hill S.J. (2004) Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation. Br. J. Pharmacol. 143, 705 714.
14. Cunha R. A. (2001) Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem. Res. 26, 979 991.
15. Cunha R. A. (2005) Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signal. 1, 111 134.
16. Cunha R. A., Constantino M. D., Fonseca E. Ribeiro J. A. (2001) Age-dependent decrease in adenosine A1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids. Eur. J. Biochem. 268, 2939 2947.
17. Cunha G. M., Canas P. M., Oliveira C. R. Cunha R. A. (2006) Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience 141, 1775 1781.
18. Dehnhardt M., Palm C., Vieten A., Bauer A. Pietrzyk U. (2007) Quantifying the A(1)AR distribution in peritumoural zones around experimental F98 and C6 rat brain tumours. J. Neurooncol. 85, 49 63.
19. Dunwiddie T. V. Masino S. A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24, 31 55.
20. Escriche M., Burgueno J., Ciruela F., Canela E. I., Mallol J., Enrich C., Lluis C. Franco R. (2003) Ligand-induced caveolae-mediated internalization of A1 adenosine receptors: morphological evidence of endosomal sorting and receptor recycling. Exp. Cell Res. 285, 72 90.
21. Fernandez M., Svenningsson P. Fredholm B. B. (1996) Adaptive changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine. Life Sci. 58, 769 776.
22. Fredholm B. B., Lindstrom K. Wallman-Johansson A. (1994) Propentofylline and other adenosine transport inhibitors increase the efflux of adenosine following electrical or metabolic stimulation of rat hippocampal slices. J. Neurochem. 62, 563 573.
23. Fredholm B. B. (1997) Adenosine and neuroprotection. Int. Rev. Neurobiol. 40, 259 280.
24. Fredholm B. B., Chen J. F., Cunha R. A., Svenningsson P. Vaugeois J. M. (2005) Adenosine and brain function. Int. Rev. Neurobiol. 63, 191 270.
25. Freeman R. S. Barone M. C. (2005) Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders. Curr. Drug Targets CNS Neurol. Disord. 4, 85 92.
26. Frenguelli B. G., Llaudet E. Dale N. (2003) High-resolution real-time recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices. J. Neurochem. 86, 1506 1515.
27. Grobben B., De Deyn P. P. Slegers H. (2002) Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res. 310, 257 270.
28. Hettinger B. D., Leid M. Murray T. F. (1998) Cyclopentyladenosine-induced homologous down-regulation of A1 adenosine receptors (A1AR) in intact neurons is accompanied by receptor sequestration but not a reduction in A1AR mRNA expression or G protein alpha-subunit content. J. Neurochem. 71, 221 230.
29. Higuchi R., Fockler C., Dollinger G. Watson R. (1993) Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y) 11, 1026 1030.
30. Jacobson K. A., von Lubitz D. K., Daly J. W. Fredholm B. B. (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol. Sci. 17, 108 113.
31. Jiang N., Kowaluk E. A., Lee C. H., Mazdiyasni H. Chopp M. (1997) Adenosine kinase inhibition protects brain against transient focal ischemia in rats. Eur. J. Pharmacol. 320, 131 137.
32. Kacimi R., Moalic J. M., Aldashev A., Vatner D. E., Richalet J. P. Crozatier B. (1995) Differential regulation of G protein expression in rat hearts exposed to chronic hypoxia. Am. J. Physiol. 269, H1865 H1873.
33. Kaur B., Khwaja F. W., Severson E. A., Matheny S. L., Brat D. J. Van Meir E. G. (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-oncol. 7, 134 153.
34. Kitakaze M., Minamino T., Node K., Komamura K., Inoue M., Hori M. Kamada T. (1996) Activation of ecto-5'-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. J. Mol. Cell. Cardiol. 28, 1945 1955.
35. Kobayashi S. Millhorn D. E. (1999) Stimulation of expression for the adenosine A2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection. J. Biol. Chem. 274, 20358 20365.
36. Kobayashi S., Beitner-Johnson D., Conforti L. Millhorn D. E. (1998a) Chronic hypoxia reduces adenosine A2A receptor-mediated inhibition of calcium current in rat PC12 cells via downregulation of protein kinase A. J. Physiol. 512, 351 363.
37. Kong T., Westerman K. A., Faigle M., Eltzschig H. K. Colgan S. P. (2006) HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20, 2242 2250.
38. Küst B. M., Biber K., van Calker D. Gebicke-Haerter P. J. (1999) Regulation of K+ channel mRNA expression by stimulation of adenosine A2a-receptors in cultured rat microglia. Glia 25, 120 130.
39. Lee K. S., Tetzlaff W. Kreutzberg G. W. (1986) Rapid down regulation of hippocampal adenosine receptors following brief anoxia. Brain Res. 380, 155 158.
40. León D., Albasanz J. L., Ruiz M. A., Fernandez M. Martin M. (2002) Adenosine A1 receptor down-regulation in mothers and fetal brain after caffeine and theophylline treatments to pregnant rats. J. Neurochem. 82, 625 634.
41. León D., Albasanz J. L., Fernandez M., Ruiz M. A. Martin M. (2004) Down-regulation of rat brain adenosine A1 receptors at the end of pregnancy. J. Neurochem. 88, 993 1002.
42. Li H. T., Long C. S., Rokosh D. G., Honbo N. Y. Karliner J. S. (1995) Chronic hypoxia differentially regulates alpha 1-adrenergic receptor subtype mRNAs and inhibits alpha 1-adrenergic receptor-stimulated cardiac hypertrophy and signaling. Circulation 92, 918 925.
43. Li H. T., Honbo N. Y. Karliner J. S. (1996) Chronic hypoxia increases beta 1-adrenergic receptor mRNA and density but not signaling in neonatal rat cardiac myocytes. Circulation 94, 3303 3310.
44. Lobner D. (2002) Saturation of neuroprotective effects of adenosine in cortical culture. Neuroreport 13, 2075 2078.
45. Lowry O. H., Rosebrough N. J., Farr A. L. Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 275.
46. von Lubitz D. K. (1999) Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol. 371, 85 102.
47. Makino Y., Kanopka A., Wilson W. J., Tanaka H. Poellinger L. (2002) Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3 alpha locus. J. Biol. Chem. 277, 32405 32408.
48. Martin E. D., Fernandez M., Perea G., Pascual O., Haydon P. G., Araque A. Cena V. (2007) Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission. Glia 55, 36 45.
49. Mehlin C., Crittenden C. Andreyka J. (2003) No-wash dyes for calcium flux measurement. Biotechniques 34, 164 166.
50. de Mendonça A., Sebastiao A. M. Ribeiro J. A. (2000) Adenosine: does it have a neuroprotective role after all? Brain Res. Brain Res. Rev. 33, 258 274.
51. Miller L. P., Jelovich L. A., Yao L., DaRe J., Ugarkar B. Foster A. C. (1996) Pre- and peristroke treatment with the adenosine kinase inhibitor, 5′-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats. Neurosci. Lett. 220, 73 76.
52. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55 63.
53. Murphy M. G., Moak C. M., Byczko Z. MacDonald W. F. (1991) Adenosine-dependent regulation of cyclic AMP accumulation in primary cultures of rat astrocytes and neurons. J. Neurosci. Res. 30, 631 640.
54. Nagasawa H., Araki T. Kogure K. (1994) Alteration of adenosine A1 receptor binding in the post-ischaemic rat brain. Neuroreport 5, 1453 1456.
55. Nelson C. P. Challiss R. A. (2007) "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem. Pharmacol. 73, 737 751.
56. Onodera H., Sato G. Kogure K. (1987) Quantitative autoradiographic analysis of muscarinic cholinergic and adenosine A1 binding sites after transient forebrain ischemia in the gerbil. Brain Res. 415, 309 322.
57. Phillis J. W., Walter G. A., O'Regan M. H. Stair R. E. (1987) Increases in cerebral cortical perfusate adenosine and inosine concentrations during hypoxia and ischemia. J. Cereb. Blood Flow Metab. 7, 679 686.
58. Phillis J. W., O'Regan M. H. Walter G. A. (1988) Effects of nifedipine and felodipine on adenosine and inosine release from the hypoxemic rat cerebral cortex. J. Cereb. Blood Flow Metab. 8, 179 185.
59. Quintero M., Mackenzie N. Brennan P. A. (2004) Hypoxia-inducible factor 1 (HIF-1) in cancer. Eur. J. Surg. Oncol. 30, 465 468.
60. Rebola N., Porciuncula L. O., Lopes L. V., Oliveira C. R., Soares-da-Silva P. Cunha R. A. (2005) Long-term effect of convulsive behavior on the density of adenosine A1 and A 2A receptors in the rat cerebral cortex. Epilepsia 46 (Suppl 5 159 165.
61. Rudolphi K. A., Schubert P., Parkinson F. E. Fredholm B. B. (1992) Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13, 439 445.
62. Ruiz A., Sanz J. M., Gonzalez-Calero G., Fernandez M., Andres A., Cubero A. Ros M. (1996) Desensitization and internalization of adenosine A1 receptors in rat brain by in vivo treatment with R-PIA: involvement of coated vesicles. Biochim. Biophys. Acta 1310, 168 174.
63. Ruiz M. A., Escriche M., Lluis C., Franco R., Martin M., Andres A. Ros M. (2000) Adenosine A(1) receptor in cultured neurons from rat cerebral cortex: colocalization with adenosine deaminase. J. Neurochem. 75, 656 664.
64. Ryan H. E., Lo J. Johnson R. S. (1998) HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005 3015.
65. Ryzhov S., McCaleb J. L., Goldstein A. E., Biaggioni I. Feoktistov I. (2007) Role of adenosine receptors in the regulation of angiogenic factors and neovascularization in hypoxia. J. Pharmacol. Exp. Ther. 320, 565 572.
66. Saura J., Angulo E., Ejarque A. et al. (2005) Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J. Neurochem. 95, 919 929.
67. Schulte G. Fredholm B. B. (2000) Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol. Pharmacol. 58, 477 482.
68. Semenza G. L. (2001) HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107, 1 3.
69. Settimo F., Primofiore G., Taliani S., Motta C., Novellino E., Greco G., Lavecchia A., Cosimelli B., ladanza M., Klotz K., Tuscano D., Trincavelli M. L. Martini C. (2004) A1 Adenosine Receptor Antagonists, 3-Aryl[1,2,4]triazino[4,3- a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2- phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): different recognition of bovine and human binding sites. Drug Develop. Res. 63, 1 7.
70. Sweeney M. I. (1997) Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci. Biobehav. Rev. 21, 207 217.
71. Trincavelli M. L., Costa B., Tuscano D., Lucacchini A. Martini C. (2002) Up-regulation of A(2A) adenosine receptors by proinflammatory cytokines in rat PC12 cells. Biochem. Pharmacol. 64, 625 631.
72. Unruh A., Ressel A., Mohamed H. G., Johnson R. S., Nadrowitz R., Richter E., Katschinski D. M. Wenger R. H. (2003) The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene 22, 3213 3220.
73. Van Wylen D. G., Park T. S., Rubio R. Berne R. M. (1986) Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J. Cereb. Blood Flow Metab. 6, 522 528.
74. Vendite D., Sanz J. M., Lopez-Alanon D. M., Vacas J., Andres A. Ros M. (1998) Desensitization of adenosine A1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells. Neurochem. Res. 23, 211 218.
75. Wang G. L., Jiang B. H., Rue E. A. Semenza G. L. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 92, 5510 5514.
76. Wei W., Ryu J. K., Choi H. B McLarnon J. G. (2008) Expression and function of the P2X(7) receptor in rat C6 glioma cells. Cancer Lett. 260, 79 87.
77. Yang Y. T., Ju T. C. Yang D. I. (2005) Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells. J. Neurochem. 93, 513 525.
78. Zimmermann H. (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol. 362, 299 309.